New guidelines from the Endocrine Society address the information gap regarding dyslipidemia screening and cardiovascular risk assessment and management in endocrine diseases beyond diabetes and obesity. The guidelines, published in The Journal of Clinical Endocrinology & Metabolism, also provide recommendations on lipid management in thyroid disease, Cushing’s syndrome, disorders of growth hormone secretion, PCOS, menopause, ...
Lipid screening should be routine for patients with endocrine diseases: guidelines
By Mardi Chapman
29 Oct 2020